SageView Advisory Group »

Cidara Therapeutics shares owned by SageView Advisory Group

Quarter-by-quarter ownership of Cidara Therapeutics (CDTX) shares owned by SageView Advisory Group from 13F filings

Historical chart of SageView Advisory Group investment in Cidara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cidara Therapeutics held by SageView Advisory Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cidara Therapeutics by SageView Advisory Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.0k 9 221.00

More positions owned by SageView Advisory Group

Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Scottsdale Fds Vng Rus1000val (VONV)
Vanguard Scottsdale Fds Vng Rus1000grw (VONG)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Vanguard Index Fds Extend Mkt Etf (VXF)
Schwab Strategic Tr Emrg Mkteq Etf (SCHE)
Ishares Tr Core Intl Aggr (IAGG)
Ishares Tr Global Reit Etf (REET)
Schwab Strategic Tr Intl Sceqt Etf (SCHC)
Apple (AAPL)
Spdr Series Trust State Street Spd (SPHY)
Ishares Tr National Mun Etf (MUB)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)

View all positions for SageView Advisory Group

Top funds holding Cidara Therapeutics

Vanguard Group
Fil
State Street Corporation
Susquehanna International
Summit Partners Public Asset Management
Verition Fund Management
Farallon Capital Management
Qube Research & Technologies
Caption Management
FMR
Adage Capital Partners GP
Marshall Wace
Vivaldi Asset Management
Charles Schwab Investment Management
Omni Event Management

View all funds holding Cidara Therapeutics